Mersana Therapeutics (NASDAQ: MRSN)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Mersana Therapeutics (NASDAQ: MRSN) through any online brokerage.
The latest price target for Mersana Therapeutics (NASDAQ: MRSN) was reported by Cantor Fitzgerald on Friday, August 12, 2022. The analyst firm set a price target for 4.00 expecting MRSN to fall to within 12 months (a possible -47.16% downside). 50 analyst firms have reported ratings in the last year.
The stock price for Mersana Therapeutics (NASDAQ: MRSN) is $7.57 last updated August 12, 2022, 8:00 PM UTC.
The next Mersana Therapeutics (MRSN) dividend date is projected to be Thursday, September 1, 2022.
Mersana Therapeutics’s FY earnings are confirmed for Wednesday, December 20, 2023.
There is no upcoming split for Mersana Therapeutics.
Mersana Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.